Brazil Aesthetic Devices Market Trends and Insights
Rapid Uptake of Minimally & Non-Invasive Procedures
Brazil performed 3.1 million aesthetic procedures in 2024 - 2.35 million surgical and 769,000 non-surgical - making it one of the top five countries worldwide. Non-surgical demand is expanding faster because treatments such as botulinum toxin and hyaluronic-acid fillers require no anesthesia, create little downtime, and can be administered in dentist offices that already own laser or radiofrequency systems. Dentists executed 43% of clinic-based procedures in 2024 and 87% of total applications, effectively bypassing dermatology bottlenecks and shortening the device-adoption cycle. Franchise operators amplify this reach; JL Health alone supplies 18 equipment brands and expects revenue to reach BRL 700 million in 2024. By widening the practitioner base, these dynamics add 2.5 percentage points to the overall CAGR of the Brazil aesthetic devices market.Growing Social-Media-Driven Beauty Consciousness
A Croma survey published in 2024 found that 72% of Brazilian men care about their looks and 68% openly discuss it, while Instagram and TikTok have become discovery engines for “before-after” content. Academic work confirms a causal link between social-media exposure and willingness to undergo procedures. Clinics package multi-modality treatments such as the “Sleeping Beauty” combo of botulinum toxin plus JetPeel for viral storytelling, pulling younger patients into routine maintenance programs. This cultural shift is especially potent among 18-34-year-olds, who are growing at a 13.82% CAGR, and it lifts the market trajectory by roughly 1.8 percentage points.High Cap-Ex for Advanced Platforms
Fractional CO₂ lasers, hybrid HIFU/RF consoles, and picosecond tattoo-removal systems cost between BRL 200,000 and BRL 1.3 million, a steep hurdle for independent clinics. With real interest rates hovering near 10% after the SELIC peaked at 14.75% in 2025, equipment leases erode profitability and delay technology upgrades. A 22% depreciation of the real in 2024 also inflated import prices. The resulting cap-ex drag trims about 1.5 percentage points off CAGR.Other drivers and restraints analyzed in the detailed report include:
- Ageing & Obesity Trends Driving Body Contouring Demand
- Device Miniaturization Spurring Home-Use Segment
- Practitioner-Training Gaps & Safety Incidents
Segment Analysis
Non-energy products represented 81.42% of the Brazil aesthetic devices market in 2025, led by 121 ANVISA-approved hyaluronic-acid fillers that generate repeat sales without large capital outlays. Allergan’s HArmonyCa hybrid and Merz’s Radiesse add collagen-stimulating options that increase procedure frequency among millennials seeking “pre-juvenation.” Implants remain a smaller category but benefit from Silimed’s 12,000 m² factory that supplies domestic clinics and exports to Mercosur neighbors.Energy-based systems - lasers, RF, IPL, and HIFU - captured 18.58% in 2025 and will grow at a 13.43% CAGR, pushing the segment’s Brazil aesthetic devices market size above USD 90 million by 2031. Clinical studies show that 1470 nm diode endolaser reduces subcutaneous fat while tightening skin, and BTL’s Emsculpt Neo has logged 55,000 Brazilian treatments that combine RF lipolysis and electromagnetic muscle stimulation. Classys’ acquisition of JL Health provides a direct path to market for the Shurink Universe HIFU system, intensifying competition against Ultherapy and Ultraformer.
Skin resurfacing and tightening accounted for 27.45% of 2025 revenue, thanks to fractional CO₂ lasers and micro-focused ultrasound that treat photodamage and laxity with minimal downtime. Hair-removal demand remains robust across diode and IPL platforms, anchored by cultural norms favoring smooth skin and falling per-session pricing.
Body-contouring revenues are poised to rise faster than any other indication, expanding at a 14.67% CAGR as obesity heads toward a 45.5% adult prevalence by 2030. Cryolipolysis, RF, and HIFU technologies appeal to both post-bariatric patients and younger consumers chasing “summer-ready” physiques. The segment could surpass 25% of the overall Brazil aesthetic devices market share by 2031 if forecast adoption rates hold.
Complete Report Scope:
- By Device Type
- Energy-based Devices
- Laser-based
- Radiofrequency
- IPL & Light-based
- Ultrasound / HIFU
- Non-energy Devices
- Dermal Fillers & Injectables
- Implants
- Microdermabrasion & Dermarollers
- Energy-based Devices
- By Application
- Skin Resurfacing & Tightening
- Hair Removal
- Body Contouring & Cellulite Reduction
- Facial Aesthetic Procedures
- Pigmented & Vascular Lesion Treatment
- Others
- By End User
- Dermatology and Asthetic Clinics
- Hospitals & Surgical Centers
- Medical Spas & Beauty Centers
- Home-use
- By Gender
- Female
- Male
- By Age Group
- 18-34 Years
- 35-50 Years
- Above 50 Years
List of Companies Covered in this Report:
- AbbVie (Allergan Aesthetics)
- BTL
- Candela Medical
- Classys
- Cutera
- Fotona
- Galderma
- Hologic
- HTM Eletrônica
- Hugel
- Ibramed Tonederm
- Lumenis
- Merz Pharma
- Sciton
- Silimed
- Sisram
- Candela Medical
- Venus Concept
- VYDENCE Medical
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie (Allergan Aesthetics)
- BTL Aesthetics
- Candela Corporation
- Classys
- Cutera Inc.
- Fotona
- Galderma
- Hologic
- HTM Eletrônica
- Hugel
- Ibramed Tonederm
- Lumenis Be Ltd
- Merz Pharma
- Sciton Inc.
- Silimed
- Sisram
- Syneron Medical
- Venus Concept
- VYDENCE Medical

